Current role
Shell Companies · Financial Services
Board Member
2025-10-17–present
David A. Berry, MD, PhD
Board Member
Oaktree Acquisition Corp. III Life Sciences (OACC)Equibles does not estimate personal net worth.
About David A. Berry, MD, PhD
David A. Berry, MD, PhD is recorded as Board Member at Oaktree Acquisition Corp. III Life Sciences (OACC) since October 17, 2025. Oaktree Acquisition Corp. III Life Sciences reported in an 8-K filed October 17, 2025 that David A. Berry, MD, PhD was appointed independent director, effective October 17, 2025. Oaktree Acquisition Corp. III Life Sciences is classified in the Shell Companies industry within the Financial Services sector. Other leadership on record at Oaktree Acquisition Corp. III Life Sciences includes Aman Kumar (Chairman), George A. Martinez (CFO), Thomas Sweeney (CFO) and 2 others.
“On October 17, 2025, the board of directors (the “Board”) of Oaktree Acquisition Corp. III Life Sciences (the “Company”) appointed David A. Berry, MD, PhD, as an independent director of the Company.”
Affiliation history
-
Current
2025-10-17–present
Company network
Leadership on record at Oaktree Acquisition Corp. III Life Sciences
- Aman Kumar Chairman
- George A. Martinez CFO
- Thomas Sweeney CFO
- David A. Berry Board Member
- Zaid Pardesi Board Member